L-161240

CAS No. 183298-68-2

L-161240( —— )

Catalog No. M34634 CAS No. 183298-68-2

L-161240 is an antimicrobial agent associated with lipid A biosynthesis with an IC50 value of 30 nM as determined by DEACET and a MIC value of 1-3 μg/ mL against wild-type E. coli.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 781 In Stock
10MG 1074 In Stock
25MG 1606 In Stock
50MG 2120 In Stock
100MG 2762 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-161240
  • Note
    Research use only, not for human use.
  • Brief Description
    L-161240 is an antimicrobial agent associated with lipid A biosynthesis with an IC50 value of 30 nM as determined by DEACET and a MIC value of 1-3 μg/ mL against wild-type E. coli.
  • Description
    L-161240 is an antimicrobial agent associated with lipid A biosynthesis with an IC50 value of 30 nM as determined by DEACET and a MIC value of 1-3 μg/ mL against wild-type E. coli.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    183298-68-2
  • Formula Weight
    308.33
  • Molecular Formula
    C15H20N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)C=1C=C(C=C(OC)C1OC)C2=N[C@@H](C(NO)=O)CO2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • IEM 1754 2HBr

    IEM 1754 2HBr is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM.

  • Lanopepden mesylate

    Lanopepden mesylate is a peptide deformylase inhibitor against Staphylococcus aureus.

  • QcrB inhibitor TB47

    QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.